Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Excellence was properly placed in the chart being a Ph 2/3 trial. The review of the basket of results by the RAs may very well make it pivotal and approvable for both adult and pediatric patients.
Yes, he and the illustrious FUDster, Investor.
Hey FUDster, are you so blind to notice that Excellence was a Ph 2/3 trial while Avatar was a Ph 3?
Silly and monotonous... like your tiresome FUD spins.
You can count on every one of your FUD spins to be called out.
That's your FUD opinion. The company clearly has the data to prove a precision medicine claim... based on a patient's genetic factors.
Precision Medicine/Platform is emphasized over the first 10 slides. (Must be quite disheartening for Investor to see.)
That would be a FUD spin of the headline. However, a more accurate interpretation is the enlightened view of a broader platform (beyond 2-73) based on additional studies. This, in addition to the successful trial results of 2-73 that will likely lead to approvals this year for AD, as well as Rett, if the Rett Syndrome org carries any weight. The overall QoL evidence is far too strong to deny. And the EMA has already reviewed the data and recommended an MAA submission for full approval.
The evidence is quite strong against your continued FUD narratives.
Taking the advice of a known FUDster will leave you broke and miss the long-term gains that will come following approvals this year.
More outrageous nonsense from a known paid FUDster! 👺
These FACTS aren't mine, they're Anavex's trial results...
Yep, different "worlds" alright... fact vs. FUD. I'm here to call out the FUD.
Yep... I'm a "pumper" who "pumps" with just the facts. You, on the other hand... 👺
A most ridiculous statement...
That goes without saying...
NBF = Nothing But a FUDster
I doubt that you did, but if you did, the technicals are indicating that you'll be chasing this higher.
And yet another one! 👺
Yeah, 👺, the two of us are big market influencers! Just another💩post of yours.
It's clearly obvious that you firmly belong on the list.
Just go and read their communications from Sept, as well as their CCs and Q&As.
Based on what's been communicated already...
- Anavex will be seeking FDA approvals for both Rett and AD, based on all their trial results, including OLE and RWE data.
- Based on the EMA's recommendation, Anavex will be submitting the MAA for full approval as early as possible this year. (I suspect that to be in Q1)
- Peer-reviewed journal article is due out any time. (I anticipate that to also be this qtr.)
Their primary focus is on FDA and EMA approvals.
As I recall, the trial size decision was based on the recommendation of a highly qualified outside consultant after reviewing the AVATAR data. Nonetheless, don't you think that RAs would be quite curious to understand the reasons behind the difference in placebo results between the trofinetide trial (1.7-pt improvement) vs the Excellence trial (8.3-pt improvement)... as well as the comparison between trofinetide treatment (4.9-pt improvement) vs blarcamesine treatment (12.9-pt improvement)? No doubt they will.
Utter BS! You aren't fooling anyone here. 👺
You just proved my point.
It's only the cabal soldiers 👺 who come to the defense... and attack the ones providing factual information.
Btw, who's "we"? Are you speaking for all FUDsters?
You finally have a list? Great! Let's see who's all on it... surely as many as the paid FUDster 👺 list of nearly 30.
Please post... can't wait to see how it compares to this one...
Says the FUD A-lister. 👺
The fight against naked shorting is ongoing, since this article...
"This (fight) could be bigger than tobacco" - FORBES article 2002
The fight to expose the counterfeit shares flooding our financial markets started decades ago. That's how big this fight is. You'll find a familiar "voice" in this Forbes article from 2002.
When you call out illegal behavior they come for you, your family and your livelihood
That's how they fight back. The closer to the target you get the dirtier and messier the fight gets.
"The victims were smallish companies traded on the Nasdaq Bulletin Board. Christian and his clients claim the Canadian bankers and others exploited lax oversight of this market by the National Association of Securities Dealers, selling stock they didn’t have–”naked” short-selling. Stockbrokers can sometimes get away with it, if the buyers of shorted shares don’t demand to see the certificates.
It’s on this very point that one alleged victim has decided to fight back. Gary Valinoti , chairman of http://JagNotes.com , a tiny media company, needed cash to build a TV station for his online stock-news service. So he agreed to take down $10 million in convertible preferred financing. It seemed to be a better deal than selling common at $3 a share.
As soon as JagNotes booked the investment, the share price began to fall. Much to Valinoti’s puzzlement, the stock continued falling, in good times and bad. He was further baffled by the list of large shareholders, required to disclose their holdings each month, which showed no selloffs. And yet by February 2001, the stock was trading at 10 cents. “Everybody I knew was buying, but who the hell was selling?” Valinoti wondered.
He concluded it had to be naked short-sellers. Instead of suing his tormentors, Valinoti decided to call their bluff. In February 2002 he announced a recapitalization plan, reconstituting JagNotes common stock into new Class A and B shares. To receive new issues, shareholders had to hand in their old stock certificates.
The recap took effect Apr. 8. As brokerages began sending in certificates on behalf of their clients, gaps appeared. Citibank’s beneficial holder list, for example, accounted for 6,300 shares; one investor claimed he owns 1.2 million shares through his Citibank account.
Brokerages that didn’t bother to demand certificates when clients bought JagNotes shares are in a jam. Morgan Stanley has a deficit of 500,000 shares, reports JagNotes. UBS Paine Webber seems to be missing 252,000 shares. Eventually brokers must collect from whoever sold them the phantom shares. Meantime they may have to buy on the open market to cover their clients’ positions. That should drive up the shares of JagNotes and generate a windfall for Valinoti, who owns 5 million shares. Recent price: 39 cents.
Expect a fierce fight. O’Quinn has already spent about $3 million on discovery. He’ll keep spending because, he says, “This could be bigger than tobacco.”
@HAMShortkiller
@BasileEsq
@faulkingtruth
@busybrands
@anna_trades
@JunkSavvy
@ace_indy_biz
@Rahraw999
@JennyL1818
@WilliamPFarran1
$FNGR $GTII $MMTLP $ENZC
https://www.forbes.com/forbes/2002/0610/046.html?sh=7b0f586319c9
Hey, you've earned it... along with all your 👺 compadres.
Don't let price manipulation make you think it's the "market". The SP would've been attacked, accompanied by the choir of FUDsters, even if the Rett results were stat. sig. It's what the collusive cabal does every time. That's why I unloaded a large position around $10, especially after Investor 👺 tipped us off that he was expecting "cherry picked data". Have recovered all those shares sub $6, since then.
Expect the manipulation to continue until approval or partnership, whichever comes first. They have over 18M collusive shorts that'll need to be covered... and they intend to cover them cheaply.
100 pages a month for you? Awesome! So... 1000 months for you to compile a 100k-pg MAA.
I'm sure Anavex can beat that time.
I already posted a bit of it. Sorry you missed it. Corruption is all around, if one chooses to open one's eyes.
How long would it take you to correctly compile 100k pages for an MAA submission?
It's hilarious to see all the FUDsters come out to attack a legitimate phone call to IR.
Y'all are stumbling over yourselves to see who can be atop the garbage heap.
You're still trailing BIOChecker, but closing quickly!
Wow! You are the most unhinged FUDster that's ever posted here... and everyone sees it.
You're making quite a mockery of yourself.
You're either another sad victim of propaganda... or a willful contributor. My guess is the latter... complicity! 👺
It was very interesting to hear what IR had to say about the collusively organized HF cabal... i.e. your handlers.
You're an idiot 🤡
I suspect that the XBI is at its bottom ($86), where it should begin a turnaround.
Hey, unhinged FUDster, go back to my post where I showed you my call to IR...
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=173655794
Which makes the rest of your crazy diatribe pure bullschitt, as usual.
You are an absolute a-hole paid FUDster who's desperate from being caught in a snare.
The FUDster list has been provided to IR. It'll be interesting to see what Anavex does with it.